Last reviewed · How we verify

NCT07123246

"Effects of Rigid Tape in Patients With Chronic Achilles Tendinopathy"

Not yet recruiting NA Last updated 14 August 2025
What this trial tests

NA trial testing Rigid Tape in Achilles Tendinopathy (AT) in 36 participants. Not yet recruiting.

Timeline
1 December 2025
Primary endpoint
1 December 2027
1 December 2028

Quick facts

Lead sponsorUniversity of Gran Rosario
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date1 December 2025
Primary completion1 December 2027
Estimated completion1 December 2028

Drugs / interventions tested

Conditions studied

Sponsor

University of Gran Rosario

Who can join

Adults 18 to 50, any sex, with Achilles Tendinopathy (AT). Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The aim of this study will be to determine the clinical effects of rigid tape in patients with chronic MAT. The secondary outcomes will be to evaluate the immediate and short term pain, the height and pain during the vertical jump, the satisfaction of the use of the tape and the global rating of change (GROC) of the intervention. This study will be a double-blinded randomized clinical trial comprising a total sample size of 36 participants with MAT of both genders and aged between 18 and 50 years. Subjects will undergo a screening process by a sports medicine doctor by different diagnostic tests to identify those presenting a diagnosis of painful MAT and then, they will be randomized into either a group performing experimental rigid tape (G1), or a group performing placebo tape (G2). The study will assess the subjects immediate and short-term tendon pain following the tape application during running and vertical jump. Also the tape satisfaction and GROC will be assessed. The rigid tape will be applied in the central portion of the Achilles tendon. Primary and secondary outcomes will be measured at baseline, immediate after the application of the tape and 72 hours after. The GROC will only be assessed at the end of the treatment. All the evaluations will be performed by a blinded physiotherapist. The patient will also be blinded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rigid Tape

Trials testing the same drug.

Other recruiting trials for Achilles Tendinopathy (AT)

Currently open trials in the same condition.

Other University of Gran Rosario trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing